| 영문 | virus | 한글 | 바이러스 |
|---|---|---|---|
| 설명 | 박테리아보다 덜 진화된, 생물과 무생물의 중간단계에 해당하는 것. 혼자서는 생존능력이 없으므로 반드시 다른 세포내에 속해 있어야 한다. 인체에 발생하는 많은 병중, 이 바이러스로 인해 발생하는 경우가 많으며, 이 때 대부분 특이한 치료법은 없는 실정이다. 일부 헤르페스바이러스 계통에는 치료약이 개발되어 있지만, 이것도 일부 질병에서만 치료가 가능하다. 또한, Ebstein-Barr virus, Human papilloma virus 등은 암의 발생과 연관되어 있으며, 동물에서 발생하는 대부분의 암종은 바이러스와 연관되어 있는 경우가 많다. 요즘, 일부 지역에서 큰 유행을 하고 있는 후천성면역결핍증후군(AIDS)도 HIV(Human Immunodeficiency Virus)와 관련이 있다. |
||
| 영문 | simian virus | 한글 | 원숭이바이러스 |
|---|---|---|---|
| 설명 | 원숭이에서 분리된 바이러스. 아데노바이러스, 엔테로바이러스, 헤르페스바이러스 및 레오바이러스 등의 여러 군에 속한다. |
||
| 영문 | influenza virus | 한글 | 인플루엔자바이러스 |
|---|---|---|---|
| 설명 | 인플루엔자의 병원체. 상기도 점막에 침입하여 호흡기 질환을 일으킨다. 보체 결합 항원의 차이에 따라 A-B-C 세형태로 나뉘며, 유행할 때마다 혈구 응집 항원이 변이하여 광범위한 유행을 나타낸다. 껍질이 있는 80~150nm의 공모양, 나선 대칭 RNA 바이러스이다. 두 종류의 스파이크, 뉴라미니다아제(neuraminidase, NA), 당단백질과 헤마글루티닌(hemagglution, HA) 당단백질을 만든다. A형의 NA에는 N1-N2의 두 종류, HA에는 HAO-HA1-HA2-HA3의 네 종류가 있다. A형은 말-돼지-새에 감염하며 새로운 아형은 동물 바이러스와의 조환형이며, 그 밖에 동일 아형내 점변이가 있다. B, C형은 사람 이외에는 감염되지 않는다. 닭의 적혈구를 응집하는 성질이 있다. 바이러스 진단에는 환자의 인두 세척액에서 분리한다든가, 또는 환자의 혈청항체에 의한 특이적 적혈구 응집저지검사, 뉴라미니다아제 활성저지검사 또는 중화검사 등으로 검출한다. |
||
| FLAIR | fluid attenuated inversion recovery |
|---|---|
| PV | pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc... |
| HEV | health and environment; hemagglutinating encephalomyelitis virus; hepatitis E virus; hepato-encephal... |
| SFV | Semliki Forest virus; shipping fever virus; Shope fibroma virus; squirrel fibroma virus |
| OPV | Oral Polio-Vaccine; 경구용 소아마비 백신 |
| HTLV-I/II | Human T cell lymphotropic virus types I and II |
|---|---|
| HSV-2 | herpes simplex virus types 1 and 2 |
| HTLV-I/II | human T lymphotropic virus types I and II |
| IPV | Inactivated Polio-Vaccine |
| OPV | Oral Polio Vaccine |
| attenuated virus | A weakened virus that is no longer virulent. Can be used to make a live virus vaccine. (12 Dec 1998) |
|---|---|
| attenuated | <microbiology, virology> To reduce the virulence (infectivity) of a pathogenic microorganism. (27 Sep 1997) |
| attenuated tuberculosis | A mild chronic form marked by caseous tubercles of the skin and the occurrence of cold abscesses. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| point system test types | A near-vision test chart in which the various test types are multiples of a point (1/72 inch), lower-case letters being one-half the designated point size; reading 4-point at 16 inches is normal, and is designated N-4. (05 Mar 2000) |
| hydatiform mole: types | <radiology> Complete/classical mole, fertilization of an empty egg; diploid karyotype (paternal XX), no foetal parts; no chorionic membrane, 20% malignant complete mole with coexistent foetus (2%), molar degeneration of an identical twin partial mole, areas of molar change alternating with normal chorionic villi, triploid karyotype (66% XXY; 33% XXX), early onset of preeclampsia, foetal structures present (e.g., placenta), no malignant potential see: hydatiform mole (12 Dec 1998) |
| Snellen's test types | Square black symbols employed in testing the acuity of distant vision; the letters vary in size in such a way that each one subtends a visual angle of 5' at a particular distance. (05 Mar 2000) |
| stomach cell types | <radiology> Parietal (oxyntic), in fundus and body, may lead to HCl (acid) and intrinsic factor, chief, in fundus and body, may lead to pepsinogen, G-cells, in antrum, mucus? (12 Dec 1998) |
| oesophageal carcinoma: types | <radiology> Histologic types: squamous cell carcinoma (95%), adenocarcinoma (4%), 70% from Barrett oesophagus, carcinosarcoma = pseudosarcoma = spindle cell squamous cell carcinoma, usually middle 1/3 of oesophagus, large, polypoid, smooth, intramural mass; may be pedunculated, mucoepidermoid carcinoma, adenoid cystic carcinoma radiologic types: polypoid/fungating form (most common), sessile/pedunculated tumour with lobulated surface, applecore lesion, ulcerating form, infiltrating form, gradual narrowing with smooth transition (Differential diagnosis: benign stricture), varicoid form: superficial spreading carcinoma, thickened nodular tortuous longitudinal folds (Differential diagnosis: varices) (12 Dec 1998) |
| test types | Letters of various sizes used to test visual acuity. (05 Mar 2000) |
| Jaeger's test types | Type of different sizes used for testing the acuity of near vision. (05 Mar 2000) |
| vaccination, polio | The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house. (12 Dec 1998) |
| polio | <virology> An epidemic viral infection which attacks the motor neurons of the anterior horns in the brainstem and spinal cord. Vaccination against this disease is recommended. (27 Sep 1997) |
| polio immunization | <virology> The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house. (21 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
트리폴리오액 - 새창
|
보령바이오파마 |
Attenuated polio Virus Types I,II,III In magnesium Chloride Solution | 전문의약품 | 비급여 |
|
|
폴리오에스코박스2ml/v - 새창
|
한국백신 |
Attenuated polio Virus Types I,II,III In magnesium Chloride Solution | 전문의약품 | 비급여 |
|
|
폴리오코박스1ml/v - 새창
|
한국백신 |
Attenuated polio Virus Types I,II,III In magnesium Chloride Solution | 전문의약품 | 비급여 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|